ARPA-H Backs Kaiser, Duke for $62.7M Autonomous AI Push
ARPA-H is betting on autonomous AI for heart care. The federal health research agency announced Sept. 9 that it selected six teams, including Kaiser Permanente and Duke, to build the first FDA-authorized agentic AI system for cardiovascular care, according to Becker's Hospital Review.
The program, named Agentic AI-EnableD CardioVascular CAre TransfOrmation, or ADVOCATE, runs four years and carries a $62.7 million budget, with up to $33.7 million available in year one. The goal is agentic AI: systems that take actions and manage care workflows autonomously rather than simply flagging findings for a clinician to review.
The effort matters because most healthcare AI cleared to date is assistive, keeping a human in the loop. Pushing toward FDA authorization for autonomous agents in a high-stakes specialty like cardiology would set a regulatory and clinical precedent. Cardiovascular disease remains the leading cause of death in the US, making it a logical, high-volume proving ground for whether agentic AI can operate safely at scale.
Sources